Divestment of radiopharmaceutical business of CIS bio international completed
09-May-2006
As part of the transaction, the consortium has acquired Schering's current radiopharmaceutical business while Schering continues to focus on the promising innovative diagnostic fields of Magnetic Resonance Imaging, Computer Tomography and optical as well as molecular imaging.
Most read news
Topics
Organizations
Cisbio international
Bayer Schering Pharma
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.